Skip to main content
padlock icon - secure page this page is secure
Recent Patents on Anti-Cancer Drug Discovery publishes review articles on recent patents in the field of anti-cancer drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 3, 2017

Articles

Free Content Meet Our Editorial Board Member
pp. 189-189(1)
Author: M. Chan, Andrew

Favourites:
ADD

Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents
pp. 190-207(18)
Authors: Lucas, Stephanie; Soave, Claire; Nabil, Gazal; Sabry Othman Ahmed, Zainab; Chen, Guohua; Awad El-Banna, Hossny; Ping Dou, Q.; Wang, Jian

Favourites:
ADD

Poly (ADP-Ribosyl) Polymerase 1 Inhibitors: A Patent Review
pp. 208-220(13)
Authors: Cao, Mengda; Sun, Xi; Zhou, Yanjun; Huang, Wen; Meng, Ling; Wei, Ji-Fu

Favourites:
ADD

Immune Cells Act as Promising Targets for the Treatment of Bone Metastasis
pp. 221-233(13)
Authors: Luo, Guojing; He, Yuedong; Zhao, Qian; Yu, Xijie

Favourites:
ADD

Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals
pp. 234-246(13)
Authors: Illam, Soorya P.; Narayanankutty, Arunaksharan; Mathew, Shaji E.; Valsalakumari, Remya; Jacob, Rosemol M.; Raghavamenon, Achuthan C.

Favourites:
ADD

Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer
pp. 247-259(13)
Authors: Zhang, Jing; Niu, Yangyang; Huang, Chen

Favourites:
ADD

Indication of Bevacizumab for Cerebral Radiation Necrosis
pp. 272-277(6)
Authors: Zhuang, Hongqing; Yuan, Xiangkun; Yuan, Zhiyong; Wang, Ping

Favourites:
ADD

Free Content Patent Selections
pp. 278-279(2)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more